Cisplatin and etoposide chemotherapy combined with early concurrent twice-daily thoracic radiotherapy for limited-disease small cell lung cancer in elderly patients

Kunio Okamoto, Isamu Okamoto, Ken Takezawa, Izumi Tachibana, Masahiro Fukuoka, Yasumasa Nishimura, Kazuhiko Nakagawa

Research output: Contribution to journalArticlepeer-review

7 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Cisplatin and etoposide chemotherapy combined with early concurrent twice-daily thoracic radiotherapy for limited-disease small cell lung cancer in elderly patients'. Together they form a unique fingerprint.

Medicine and Dentistry